Researchers addressed B - cell lines and
human Islet cells with preparations of turmeric and observed positive benefits.
We observed that this pathogenic process was active in
human islet cells obtained from donors with type 2 diabetes... [7]
Initially, Novocell experimented with implanting micro-encapsulated
human islet cells.
TIMP - 1, previously described as being able to protect against cytokine and STZ ‐ induced β cell death [5, 6], was one of the most enriched factors in co-culture experiments using mouse and
human islet cells, and the authors found that TIMP - 1 was induced by pro-inflammatory factors which are commonly associated with T1DM.
San Diego, CA (December 9, 2008)-- Novocell, Inc., a stem cell engineering company, today announced a collaboration with renowned stem cell researcher Dr. Shinya Yamanaka of Kyoto University, Japan, to allow Novocell to explore the creation of
human islet cells from induced pluripotent stem (iPS) cells.
Novocell also demonstrated earlier this year, that hES - derived pancreatic progenitorsdevelop into
human islet cells capable of producing insulin in response to glucose and ameliorating diabetes in animal models.
Image of non-diabetic healthy
human islet cells that reside in pancreas.
Doug Melton has put in a life - time of hard work in finding a way of generating
human islet cells in vitro.
«This is a unique and valuable resource for researchers wishing to begin to understand how gene expression is dynamically regulated in
human islet cells,» said Kim.
«Studying
human islet cells has been a major challenge in the field of diabetes research for decades because the pancreas essentially digests itself shortly after a person's death,» said professor of developmental biology Seung Kim, MD, PhD.
Not exact matches
Using
cells from cadavers, doctors have been experimentally transplanting pancreatic
islets into
humans for decades, but as many as 60 percent of the transplanted
islets die immediately because they are cut off from their blood supply and are killed by an immune response due to direct injection into the bloodstream, and those that survive the transplant usually die within several months.
In addition to looking at mouse models of diabetes, the researchers also showed that exposure of
human pancreatic
islet cells — both from healthy donors and from patients with Type 1 diabetes — to fasting - mimicking diet in a dish stimulated insulin production.
Whatever the source of pluripotent
cells, Thomson says, researchers face the same scientific challenges — namely, understanding how to convert them into key tissues such as the beta
islet cells that are impaired in diabetics, and then how to introduce them safely and effectively into
humans.
This is an image of
human stem
cell - derived beta
cells that have formed
islet like clusters in a mouse.
Investigators found that autophagy plays a role in clearing IAPP from pancreatic beta
cells using three experimental models: pancreatic beta
cells, isolated pancreatic
islets from mice that express the
human form of IAPP, and
human islets.
To corroborate the findings, the researchers also developed a novel mouse model that was deficient for autophagy specifically in beta
cells with expression of the
human form of
islet amyloid polypeptide.
In these two microscopy images,
human islets (the source of insulin
cells) were poisoned with a drug to remove the insulin
cells, and then treated with either an empty virus (left panel) or the therapeutic virus (right panel), and then grown in a diabetic mouse.
Replication increases β -
cell vulnerability to
human islet amyloid polypeptide - induced apoptosis
Autopsy studies in
humans suggest that
islet amyloid is associated with the loss of β
cells mass (Clark et al., 1988).
Diabetes due to a progressive defect in β -
cell mass in rats transgenic for
human islet amyloid polypeptide (HIP rat): A new model for type 2 diabetes
«ViaCyte was the first to differentiate
human stem
cells into glucose - responsive, insulin - producing
cells, and now we are running the first and only clinical trials of stem
cell - derived
islet replacement therapies for type 1 diabetes,» said Paul Laikind, PhD, President and CEO of ViaCyte.
Maturation of
human embryonic stem
cell - derived pancreatic progenitors into functional
islets capable of treating pre-existing diabetes in mice.
Paracrine signalling loops in adult
human and mouse pancreatic
islets: netrins modulate beta
cell apoptosis signalling via dependence receptors.
Coating
Human Pancreatic
Islets With CD4 + CD25highCD127 - Regulatory T
Cells as a Novel Approach for the Local Immunoprotection.
Following implantation, the
cells should develop into
human islet tissue, capable of regulating blood glucose.
Assessment of hASC - CM composition found high expression of various
human growth factors (IL ‐ 6, 8, 12, eotaxin, IP10, MCP ‐ 1, VEGF, and TIMP ‐ 1) in the supernatant following the co-culture of hASCs with
islet cells, while IP10, eotaxin, VEGF, and TIMP ‐ 1 became increased with time during
islet co ‐ culture, suggesting the presence of paracrine cross ‐ talk between
islets and hASCs.
The Emory Transplant Center has conducted clinical trials since 2003 transplanting
human pancreatic
islet cells into patients with Type I diabetes.
But the application describes ViaCyte's technology, which grows pancreatic «
islet»
cells from
human embryonic stem
cells.
The pluripotent stem
cell process could allow researchers to make genetic changes to dampen or potentially eliminate the rejection of the pig
islets by the
human immune system.
Chong Wee Liew, Ph.D., lead author and a postdoctoral researcher in the Kulkarni lab, first examined the expression of the tribbles protein in pancreatic
islets (which house beta
cells and other hormone - producing
cells) in both
humans and mice.
After implantation, these
cells are expected to become mature
human islet tissue including well - regulated beta
cells producing insulin on demand.
The markers highlighted the striking diversity of beta
cell aging, and functional decline, both within and between
islets in both mouse and
human pancreases.
Methods: Here we model
human β -
cell dedifferentiation using growth factor stimulation in the
human β -
cell line, EndoC - βH1, and
human pancreatic
islets.
Poster: In vitro generation of insulin producing
cells with insulin secretion kinetics and mitochondrial respiration similar to adult
human islets [Poster T2190] Speaker: Dr. Alireza Rezania, Senior Director, Discovery Date / Time: June 23, 7:00 p.m. to 8:00 p.m., PDT
Human islet amyloid polypeptide expression in COS - 1
cells.